Hasil Pencarian - Kevin Chin
- Menampilkan 1 - 4 hasil dari 4
-
1
ENAP1 retrains seed germination via H3K9 acetylation mediated positive feedback regulation of ABI5. oleh Bo Zhao, Likai Wang, Zhengyao Shao, Kevin Chin, Daveraj Chakravarty, Hong Qiao
Diterbitkan 2021-12-01Dapatkan teks lengkap
Artikel -
2
Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab oleh Nadia Terranova, Jonathan French, Haiqing Dai, Matthew Wiens, Akash Khandelwal, Ana Ruiz‐Garcia, Juliane Manitz, Anja vonHeydebreck, Mary Ruisi, Kevin Chin, Pascal Girard, Karthik Venkatakrishnan
Diterbitkan 2022-03-01Dapatkan teks lengkap
Artikel -
3
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial oleh Ulrich Keilholz, Janice M. Mehnert, Sebastian Bauer, Hugues Bourgeois, Manish R. Patel, Donald Gravenor, John J. Nemunaitis, Matthew H. Taylor, Lucjan Wyrwicz, Keun-Wook Lee, Vijay Kasturi, Kevin Chin, Anja von Heydebreck, James L. Gulley
Diterbitkan 2019-01-01Dapatkan teks lengkap
Artikel -
4
Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma oleh Arun Rajan, Christopher R. Heery, Anish Thomas, Andrew L. Mammen, Susan Perry, Geraldine O’Sullivan Coyne, Udayan Guha, Arlene Berman, Eva Szabo, Ravi A. Madan, Leomar Y. Ballester, Stefania Pittaluga, Renee N. Donahue, Yo-Ting Tsai, Lauren M. Lepone, Kevin Chin, Fiona Ginty, Anup Sood, Stephen M. Hewitt, Jeffrey Schlom, Raffit Hassan, James L. Gulley
Diterbitkan 2019-10-01Dapatkan teks lengkap
Artikel